Search

Michael P. Barker

Examiner (ID: 19383, Phone: (571)272-0303 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1626, 1655, OPQA
Total Applications
1330
Issued Applications
1017
Pending Applications
61
Abandoned Applications
256

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16188510 [patent_doc_number] => 20200229359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => CANNABIS FARMING METHODS [patent_app_type] => utility [patent_app_number] => 16/827579 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 463 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827579 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/827579
Cannabis farming methods Mar 22, 2020 Issued
Array ( [id] => 16320192 [patent_doc_number] => 10780139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-09-22 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 16/823808 [patent_app_country] => US [patent_app_date] => 2020-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 7516 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823808 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/823808
None Mar 18, 2020 Issued
Array ( [id] => 18801304 [patent_doc_number] => 11834455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Carm1 inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 16/822478 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 66911 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 531 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822478 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/822478
Carm1 inhibitors and uses thereof Mar 17, 2020 Issued
Array ( [id] => 18801304 [patent_doc_number] => 11834455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Carm1 inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 16/822478 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 66911 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 531 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822478 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/822478
Carm1 inhibitors and uses thereof Mar 17, 2020 Issued
Array ( [id] => 16374993 [patent_doc_number] => 20200323835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => TREATMENT FOR DOPAMINERGIC DISORDERS [patent_app_type] => utility [patent_app_number] => 16/788463 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788463 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/788463
TREATMENT FOR DOPAMINERGIC DISORDERS Feb 11, 2020 Abandoned
Array ( [id] => 16189284 [patent_doc_number] => 20200230133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => Discrete PEG Constructs [patent_app_type] => utility [patent_app_number] => 16/785693 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25221 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785693 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/785693
Discrete PEG Constructs Feb 9, 2020 Abandoned
Array ( [id] => 16990097 [patent_doc_number] => 20210228517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => ANTICANCER DRUG EFFECT ENHANCER [patent_app_type] => utility [patent_app_number] => 17/267337 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8142 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267337 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267337
Anticancer drug effect enhancer Feb 4, 2020 Issued
Array ( [id] => 18642424 [patent_doc_number] => 11766477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Methods for making mixed allergen compositions [patent_app_type] => utility [patent_app_number] => 16/750522 [patent_app_country] => US [patent_app_date] => 2020-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10084 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750522 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/750522
Methods for making mixed allergen compositions Jan 22, 2020 Issued
Array ( [id] => 16153583 [patent_doc_number] => 20200215024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => CANNABINOID FORMULATIONS FOR TREATING ALCOHOL HANGOVER [patent_app_type] => utility [patent_app_number] => 16/737413 [patent_app_country] => US [patent_app_date] => 2020-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737413 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/737413
CANNABINOID FORMULATIONS FOR TREATING ALCOHOL HANGOVER Jan 7, 2020 Abandoned
Array ( [id] => 15862593 [patent_doc_number] => 20200138700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => HYPOTONIC MICROBICIDAL FORMULATIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/717570 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717570 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/717570
Hypotonic microbicidal formulations and methods of use Dec 16, 2019 Issued
Array ( [id] => 16892007 [patent_doc_number] => 11033533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => (2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid [patent_app_type] => utility [patent_app_number] => 16/715722 [patent_app_country] => US [patent_app_date] => 2019-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 21739 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715722 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/715722
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Dec 15, 2019 Issued
Array ( [id] => 15765893 [patent_doc_number] => 20200113964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALOPECIA COMPRISING EREMOCHLOA OPHIUROIDES EXTRACT OR FRACTIONS THEREOF AS AN ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 16/712060 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712060 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/712060
Pharmaceutical composition for the prevention or treatment of alopecia comprising Dec 11, 2019 Issued
Array ( [id] => 18461453 [patent_doc_number] => 11685736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-27 [patent_title] => P2X [patent_app_type] => utility [patent_app_number] => 16/704264 [patent_app_country] => US [patent_app_date] => 2019-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 49484 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704264 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/704264
P2X Dec 4, 2019 Issued
Array ( [id] => 16420497 [patent_doc_number] => 20200345695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 16/700866 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700866 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/700866
Therapeutic agent for keratoconjunctive disorders Dec 1, 2019 Issued
Array ( [id] => 15676925 [patent_doc_number] => 20200093126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => COMPOSITION BASED ON NORDIHYDROGUAIARETIC ACID [patent_app_type] => utility [patent_app_number] => 16/693330 [patent_app_country] => US [patent_app_date] => 2019-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693330 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/693330
Composition based on nordihydroguaiaretic acid Nov 23, 2019 Issued
Array ( [id] => 16776411 [patent_doc_number] => 20210113488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Paraffin Wax with CBD Isolate [patent_app_type] => utility [patent_app_number] => 16/660007 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660007 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/660007
Paraffin wax with CBD isolate Oct 21, 2019 Issued
Array ( [id] => 16125781 [patent_doc_number] => 10696630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Urea derivative or pharmacologically acceptable salt thereof [patent_app_type] => utility [patent_app_number] => 16/580909 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70015 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580909 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/580909
Urea derivative or pharmacologically acceptable salt thereof Sep 23, 2019 Issued
Array ( [id] => 15615935 [patent_doc_number] => 20200078372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL [patent_app_type] => utility [patent_app_number] => 16/571953 [patent_app_country] => US [patent_app_date] => 2019-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571953 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/571953
Use of vanadium compounds for maintaining normaglycemia in a mammal Sep 15, 2019 Issued
Array ( [id] => 16336485 [patent_doc_number] => 10787429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-09-29 [patent_title] => Products and methods of mechanical extraction and purification of tetrahydrocannabinolic acid [patent_app_type] => utility [patent_app_number] => 16/556128 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4374 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/556128
Products and methods of mechanical extraction and purification of tetrahydrocannabinolic acid Aug 28, 2019 Issued
Array ( [id] => 15342629 [patent_doc_number] => 20200009206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => METHOD FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES [patent_app_type] => utility [patent_app_number] => 16/550150 [patent_app_country] => US [patent_app_date] => 2019-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16550150 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/550150
Method for preparation of pharmacologically-relevant compounds from botanical sources Aug 22, 2019 Issued
Menu